Simplex Trading’s Lipocine LPCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-229
Closed -$1K 9657
2022
Q4
$1K Buy
229
+23
+11% +$168 ﹤0.01% 8859
2022
Q3
$1K Sell
206
-23
-10% -$257 ﹤0.01% 9567
2022
Q2
$3K Sell
229
-2,606
-92% -$40.6K ﹤0.01% 9162
2022
Q1
$66K Buy
2,835
+2,635
+1,318% +$55.1K ﹤0.01% 6743
2021
Q4
$3K Sell
200
-4,259
-96% -$79.1K ﹤0.01% 9836
2021
Q3
$106K Hold
4,459
﹤0.01% 6537
2021
Q2
$106K Buy
4,459
+4,435
+18,479% +$104K ﹤0.01% 6643
2021
Q1
$62K Buy
24
+23
+2,300% +$664 ﹤0.01% 6348
2020
Q4
$3K Sell
1
-19
-95% -$457 ﹤0.01% 7882
2020
Q3
$48K Buy
+20
New +$531 ﹤0.01% 5641
2019
Q4
Sell
-2
Closed -$9K 7656
2019
Q3
$9K Sell
2
-1
-33% -$40 ﹤0.01% 6299
2019
Q2
$9K Hold
3
﹤0.01% 6176
2019
Q1
$11K Buy
+3
New +$92 ﹤0.01% 6100
2018
Q4
Sell
-1
Closed -$1K 7454
2018
Q3
$1K Hold
1
﹤0.01% 7201
2018
Q2
$1K Hold
1
﹤0.01% 7162
2018
Q1
$2K Sell
1
-5
-83% -$139 ﹤0.01% 5295
2017
Q4
$5K Buy
+6
New +$373 ﹤0.01% 4515
2017
Q3
Sell
-16
Closed -$31K 6285
2017
Q2
$31K Buy
+16
New +$1.04K ﹤0.01% 2841
2016
Q3
Sell
-4
Closed -$10K 6161
2016
Q2
$10K Buy
4
+2
+100% +$310 ﹤0.01% 3606
2016
Q1
$19K Hold
2
﹤0.01% 2851
2015
Q4
$1K Buy
+2
New +$420 ﹤0.01% 4903

Other funds holding LPCN

Simplex Trading's LPCN Position: Q4 2020 in Review

Simplex Trading sold out of Lipocine (LPCN) in Q4 2020, closing a stake of 1,561 shares — an estimated $37.6K sold.

Simplex Trading first reported a position in LPCN in Q4 2015 and held it in 15 quarters. The position peaked at $251K in Q2 2017. 33 funds tracked by Wall St. Rank hold LPCN as of Q4 2020.

  • Simplex Trading reported no remaining Lipocine position as of Q4 2020 after selling out during the quarter.
  • Simplex Trading sold 1,561 Lipocine shares in Q4 2020, an estimated $37.6K.
  • Simplex Trading first reported a position in Lipocine in Q4 2015 and held it in 15 quarters.
  • Simplex Trading's Lipocine position peaked at $251K in Q2 2017.
  • 33 funds tracked by Wall St. Rank held Lipocine as of Q4 2020.

Based on Simplex Trading's 13F filing for Q4 2020, filed 2 Feb 2021.